In vivo and in vitro production options for fungal secondary metabolites.
about
From Discovery to Production: Biotechnology of Marine Fungi for the Production of New AntibioticsMetabolic engineering for the production of natural products.Small-molecule elicitation of microbial secondary metabolitesTwo induced fungal polyketide pathways converge into antiproliferative spiroanthrones.Unlocking fungal cryptic natural products.Activation of the dormant secondary metabolite production by introducing gentamicin-resistance in a marine-derived Penicillium purpurogenum G59Enhancement of Palmarumycins C(12) and C(13) production in liquid culture of endophytic fungus Berkleasmium sp. Dzf12 after treatments with metal ions.Homologous NRPS-like gene clusters mediate redundant small-molecule biosynthesis in Aspergillus flavus.Chemical characterization of bioactive compounds from the endophytic fungus Diaporthe helianthi isolated from Luehea divaricata.A Novel Metabolite from Aspergillus ochraceus JGI 25 Showing Cytotoxicity to Hela Cells.Three new and eleven known unusual C25 steroids: activated production of silent metabolites in a marine-derived fungus by chemical mutagenesis strategy using diethyl sulphate.Activation of dormant secondary metabolite production by introducing neomycin resistance into the deep-sea fungus, Aspergillus versicolor ZBY-3.A practical strategy to discover new antitumor compounds by activating silent metabolite production in fungi by diethyl sulphate mutagenesis.New compound with DNA Topo I inhibitory activity purified from Penicillium oxalicum HSY05.Characterization of the Suillus grevillei quinone synthetase GreA supports a nonribosomal code for aromatic α-keto acids.Cytotoxic pheofungins from an engineered fungus impaired in posttranslational protein modification.Bioprospecting of South African Plants as a Unique Resource for Bioactive Endophytic Microbes.Lead Compounds from Mangrove-Associated Microorganisms
P2860
Q26741807-9D0BA23C-E8C0-4BD6-967E-E4C328A07A27Q33829836-68252A00-8596-4559-9E43-1DB41627016BQ33837376-74CD2A27-52D7-4B9C-8C5D-BBBB2D8BA360Q33941464-B9BCAB98-1F6C-4962-97B4-45CB0FD550B0Q35003959-D765FB64-1805-47AF-A4E2-0D7412CC40AEQ35942623-391D1DE4-384C-44EA-BFF7-79DEF26D11ABQ36589987-C3DC9B50-840C-4A69-B482-41DC79F28AB4Q37136619-AD752549-98FE-4C08-A5FD-02958F7667A7Q37160014-2D7A63B2-4E39-4B91-80DB-95F9C6543EFCQ37423977-907E807F-9B30-45F5-B18D-F78B58F67905Q38535538-98554BE6-577C-4FFA-9EA7-D19430E4C453Q38970268-4329EC83-F548-444F-9AA6-A37ABBA0D113Q39010289-71F6C6E5-B17D-43BC-AC8A-1CAADE80143AQ40947405-2BCE3E2D-0697-4FA2-BFB5-E4EF70CB6C20Q43739479-EFA5900D-6699-4CE0-8BCE-5301C6C203EBQ44406730-FA1E20D7-2E72-4AA5-9FB3-3D281A48703BQ55084653-3304F375-6E48-4ED2-AF40-21B89A98F5EEQ58758253-F6623BBC-EE12-4A9C-B917-24DD3D7FE591
P2860
In vivo and in vitro production options for fungal secondary metabolites.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vivo and in vitro production options for fungal secondary metabolites.
@en
In vivo and in vitro production options for fungal secondary metabolites.
@nl
type
label
In vivo and in vitro production options for fungal secondary metabolites.
@en
In vivo and in vitro production options for fungal secondary metabolites.
@nl
prefLabel
In vivo and in vitro production options for fungal secondary metabolites.
@en
In vivo and in vitro production options for fungal secondary metabolites.
@nl
P2093
P356
P1476
In vivo and in vitro production options for fungal secondary metabolites.
@en
P2093
Dirk Hoffmeister
Mathias Misiek
Patrick Schneider
P304
P356
10.1021/MP7001544
P407
P577
2008-03-11T00:00:00Z